ASX Announcements

ASX Announcements

2011 — Quarter 1

Keyword Search

	Code		Title	Date
	ACR		Axiron Launched by Eli Lilly in the United States	31/03/2011
	ACR		Acrux Declares First Dividend of 60 cents per share	24/03/2011
	ACR		Appendix 3B	16/03/2011
	ACR		Acrux Files Half Year Results	24/02/2011
	ACR		Half Year Accounts and Appendix 4D	24/02/2011
	ACR		Appendix 3B	15/02/2011
	ACR		Ceasing to be a substantial holder	04/02/2011
	ACR		Appendix 4C - Quarterly Cash Flow Report	31/01/2011
	ACR		Appendix 3B	21/01/2011
	ACR		Regulatory update on animal health product	13/01/2011

2011 — Quarter 2

Keyword Search

	Code		Title	Date
	ACR		Acrux receives marketing approval for Ellavie in Sweden	27/05/2011
	ACR		Appendix 3B	12/05/2011
	ACR		Positive European opinion for first animal health product	10/05/2011
	ACR		Appendix 4C - Quarterly Cash Flow Report	29/04/2011
	ACR		Appendix 3B	07/04/2011

2011 — Quarter 3

Keyword Search

	Code		Title	Date
	ACR		Market Update	28/09/2011
	ACR		SandP Indices Announces September Quarterly Rebalance	09/09/2011
	ACR		Change in substantial holding	08/09/2011
	ACR		SandP Indices Announces September SP/ASX 200 Rebalance	02/09/2011
	ACR		Change of Director`s Interest Notice	31/08/2011
	ACR		Final Director`s Interest Notice	31/08/2011
	ACR		Acrux founder Barrie Finnin retires from the board	31/08/2011
	ACR		Acrux not required to file quarterly cash flow reports	31/08/2011
	ACR		Eli Lilly Report to Acrux Investment Community	23/08/2011
	ACR		2010/11 Financial Results	23/08/2011
	ACR		Acrux Reports Full Year Profit of $57 Million	23/08/2011
	ACR		Appendix 4E and Financial Report for the year ended 30 June	23/08/2011
	ACR		Change in substantial holding	02/08/2011
	ACR		Appendix 4C - Quarterly Cash Flow Report	29/07/2011
	ACR		Change in substantial holding	18/07/2011
	ACR		Eli Lilly provides feedback on initial uptake of Axiron	01/07/2011

2011 — Quarter 4

Keyword Search

	Code		Title	Date
	ACR		Orion manufacturing facility update	01/12/2011
	ACR		Orion manufacturing facility, Finland	24/11/2011
	ACR		2011 AGM Results of Meeting	23/11/2011
	ACR		2011 AGM CEO Presentation	23/11/2011
	ACR		2011 AGM Chairman`s Address	23/11/2011
	ACR		Change of Director`s Interest Notice	04/11/2011
	ACR		2026 patent for Axiron granted by Australian patent office	03/11/2011
	ACR		2011 AGM Notice and Proxy Form	21/10/2011
	ACR		2011 Annual Report	21/10/2011
	ACR		Marketing authorisation for Recuvyra granted in Europe	13/10/2011